Future directions in pharmacogenomics discovery in cardiovascular disease.
Publication
, Journal Article
Friede, KA; Voora, D
Published in: Pharmacogenomics
April 2018
Duke Scholars
Published In
Pharmacogenomics
DOI
EISSN
1744-8042
Publication Date
April 2018
Volume
19
Issue
5
Start / End Page
375 / 377
Location
England
Related Subject Headings
- Pharmacology & Pharmacy
- Pharmacogenetics
- Humans
- Genome-Wide Association Study
- Forecasting
- Drug Hypersensitivity
- Dideoxynucleosides
- Cardiovascular Diseases
- Anti-HIV Agents
- 3214 Pharmacology and pharmaceutical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Friede, K. A., & Voora, D. (2018). Future directions in pharmacogenomics discovery in cardiovascular disease. Pharmacogenomics, 19(5), 375–377. https://doi.org/10.2217/pgs-2018-0002
Friede, Kevin A., and Deepak Voora. “Future directions in pharmacogenomics discovery in cardiovascular disease.” Pharmacogenomics 19, no. 5 (April 2018): 375–77. https://doi.org/10.2217/pgs-2018-0002.
Friede KA, Voora D. Future directions in pharmacogenomics discovery in cardiovascular disease. Pharmacogenomics. 2018 Apr;19(5):375–7.
Friede, Kevin A., and Deepak Voora. “Future directions in pharmacogenomics discovery in cardiovascular disease.” Pharmacogenomics, vol. 19, no. 5, Apr. 2018, pp. 375–77. Pubmed, doi:10.2217/pgs-2018-0002.
Friede KA, Voora D. Future directions in pharmacogenomics discovery in cardiovascular disease. Pharmacogenomics. 2018 Apr;19(5):375–377.
Published In
Pharmacogenomics
DOI
EISSN
1744-8042
Publication Date
April 2018
Volume
19
Issue
5
Start / End Page
375 / 377
Location
England
Related Subject Headings
- Pharmacology & Pharmacy
- Pharmacogenetics
- Humans
- Genome-Wide Association Study
- Forecasting
- Drug Hypersensitivity
- Dideoxynucleosides
- Cardiovascular Diseases
- Anti-HIV Agents
- 3214 Pharmacology and pharmaceutical sciences